Abstract
In studies to develop an oral rabies vaccine for wildlife, the immune response to and pathogenicity of two types of mutants of rabies viruses were examined. Forty-five small plaque mutants were selected from cultures of ERA rabies virus treated with 8-azaguanine or 5-fluorouracil and tested for pathogenicity in mice. Two of these mutants AZA 1 and AZA 2 (low pathogenicity in mice) were given to skunks by oral (bait), intestinal (endoscope) and intramuscular routes. Additionally, challenge virus standard (CVS) rabies virus and mutants of this and ERA rabies virus (CVS 3766 and 3713, and ERA 3629) that were resistant to neutralization by specific antiglycoprotein monoclonal antibodies (and apathogenic in mice) were tested by various routes in skunks. Skunks given AZA 1 and AZA 2 were challenged at three months postinoculation with street rabies virus. After oral administration, there were very low rates of seroconversion with AZA 1 and AZA 2 and on challenge only 2/7 given AZA 1 and 1/8 given AZA 2 survived. None of the skunks given the other mutants orally seroconverted. AZA 2 produced a high rate of seroconversion (8/8) by the intestinal route and all challenged skunks in this group survived (7/7). All skunks vaccinated intramuscularly with AZA 1 (4/4) or AZA 2 (4/4) developed high levels of rabies neutralizing antibodies and survived challenge. The mutant CVS 3766, while apathogenic when given intracerebrally to adult mice, was consistently pathogenic by this route (and intranasally) in skunks. These results demonstrate that skunks are highly resistant to oral immunization by live rabies virus vaccines and that pathogenicity (by intracerebral route) of the mutant CVS 3766 is markedly different in mice and skunks.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baer G. M., Abelseth M. K., Debbie J. G. Oral vaccination of foxes against rabies. Am J Epidemiol. 1971 Jun;93(6):487–490. doi: 10.1093/oxfordjournals.aje.a121283. [DOI] [PubMed] [Google Scholar]
- Black J. G., Lawson K. F. Further studies of sylvatic rabies in the fox (Vulpes vulpes). Vaccination by the oral route. Can Vet J. 1973 Sep;14(9):206–211. [PMC free article] [PubMed] [Google Scholar]
- Black J. G., Lawson K. F. Sylvatic rabies studies in the silver fox (Vulpes vulpes). Susceptibility and immune response. Can J Comp Med. 1970 Oct;34(4):309–311. [PMC free article] [PubMed] [Google Scholar]
- Black J. G., Lawson K. F. The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine. Can J Comp Med. 1980 Apr;44(2):169–176. [PMC free article] [PubMed] [Google Scholar]
- Charlton K. M., Casey G. A. Experimental rabies in skunks: immunofluorescence light and electron microscopic studies. Lab Invest. 1979 Jul;41(1):36–44. [PubMed] [Google Scholar]
- Charlton K. M., Casey G. A. Experimental rabies in skunks: oral, nasal, tracheal and intestinal exposure. Can J Comp Med. 1979 Apr;43(2):168–172. [PMC free article] [PubMed] [Google Scholar]
- Charlton K. M., Webster W. A., Casey G. A., Rhodes A. J., Macinnes C. D., Lawson K. F. Recent advances in rabies diagnosis and research. Can Vet J. 1986 Feb;27(2):85–89. [PMC free article] [PubMed] [Google Scholar]
- Clark H. F., Koprowski H. Isolation of temperature-sensitive conditional lethal mutants of "fixed" rabies virus. J Virol. 1971 Mar;7(3):295–300. doi: 10.1128/jvi.7.3.295-300.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clark H. F. Rabies viruses increase in virulence when propagated in neuroblastoma cell culture. Science. 1978 Mar 10;199(4333):1072–1075. doi: 10.1126/science.628831. [DOI] [PubMed] [Google Scholar]
- Coulon P., Rollin P., Aubert M., Flamand A. Molecular basis of rabies virus virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies. J Gen Virol. 1982 Jul;61(Pt 50):97–100. doi: 10.1099/0022-1317-61-1-97. [DOI] [PubMed] [Google Scholar]
- Dean D. J., Abelseth M. K. Laboratory techniques in rabies: the fluorescent antibody test. Monogr Ser World Health Organ. 1973;(23):73–84. [PubMed] [Google Scholar]
- Debbie J. G., Abelseth M. K., Baer G. M. The use of commercially available vaccines for the oral vaccination of foxes against rabies. Am J Epidemiol. 1972 Sep;96(3):231–235. doi: 10.1093/oxfordjournals.aje.a121453. [DOI] [PubMed] [Google Scholar]
- Dietzschold B., Wunner W. H., Wiktor T. J., Lopes A. D., Lafon M., Smith C. L., Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A. 1983 Jan;80(1):70–74. doi: 10.1073/pnas.80.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kathol R. G., Cox T. A., Corbett J. J., Thompson H. S., Clancy J. Functional visual loss: II. Psychiatric aspects in 42 patients followed for 4 years. Psychol Med. 1983 May;13(2):315–324. doi: 10.1017/s0033291700050935. [DOI] [PubMed] [Google Scholar]
- Lawson K. F., Black J. G., Charlton K. M., Johnston D. H., Rhodes A. J. Safety and immunogenicity of a vaccine bait containing ERA strain of attenuated rabies virus. Can J Vet Res. 1987 Oct;51(4):460–464. [PMC free article] [PubMed] [Google Scholar]
- Lawson K. F., Johnston D. H., Patterson J. M., Black J. G., Rhodes A. J., Zalan E. Immunization of foxes Vulpes vulpes by the oral and intramuscular routes with inactivated rabies vaccines. Can J Comp Med. 1982 Oct;46(4):382–385. [PMC free article] [PubMed] [Google Scholar]
- Mayr A., Kraft H., Jaeger O., Haacke H. Orale Immunisierung von Füchsen gegen Tollwut. Zentralbl Veterinarmed B. 1972 Sep;19(8):615–625. [PubMed] [Google Scholar]
- Steck F., Wandeler A., Bichsel P., Capt S., Häfliger U., Schneider L. Oral immunization of foxes against rabies. Laboratory and field studies. Comp Immunol Microbiol Infect Dis. 1982;5(1-3):165–171. doi: 10.1016/0147-9571(82)90031-5. [DOI] [PubMed] [Google Scholar]
- Steck F., Wandeler A., Bichsel P., Capt S., Schneider L. Oral immunisation of foxes against rabies. A field study. Zentralbl Veterinarmed B. 1982 Jun;29(5):372–396. doi: 10.1111/j.1439-0450.1982.tb01237.x. [DOI] [PubMed] [Google Scholar]
- Tolson N. D., Charlton K. M., Casey G. A., Knowles M. K., Rupprecht C. E., Lawson K. F., Campbell J. B. Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein. Arch Virol. 1988;102(3-4):297–301. doi: 10.1007/BF01310835. [DOI] [PubMed] [Google Scholar]
- Tolson N. D., Charlton K. M., Lawson K. F., Campbell J. B., Stewart R. B. Studies of ERA/BHK-21 rabies vaccine in skunks and mice. Can J Vet Res. 1988 Jan;52(1):58–62. [PMC free article] [PubMed] [Google Scholar]
- Tolson N. D., Charlton K. M., Stewart R. B., Campbell J. B., Wiktor T. J. Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res. 1987 Jul;51(3):363–366. [PMC free article] [PubMed] [Google Scholar]
- Wandeler A. I., Bauder W., Prochaska S., Steck F. Small mammal studies in a SAD baiting area. Comp Immunol Microbiol Infect Dis. 1982;5(1-3):173–176. doi: 10.1016/0147-9571(82)90032-7. [DOI] [PubMed] [Google Scholar]
- Wiktor T. J., Macfarlan R. I., Foggin C. M., Koprowski H. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies. Dev Biol Stand. 1984;57:199–211. [PubMed] [Google Scholar]
- Wild T. F., Bijlenga G. A rabies virus persistent infection in BHK21 cells. J Gen Virol. 1981 Nov;57(Pt 1):169–177. doi: 10.1099/0022-1317-57-1-169. [DOI] [PubMed] [Google Scholar]
- Winkler W. G., McLean R. G., Cowart J. C. Vaccination of foxes against rabies using ingested baits. J Wildl Dis. 1975 Jul;11(3):382–388. doi: 10.7589/0090-3558-11.3.382. [DOI] [PubMed] [Google Scholar]
- Zalan E., Wilson C., Pukitis D. A microtest for the quantitation of rabies virus neutralizing antibodies. J Biol Stand. 1979 Jul;7(3):213–220. doi: 10.1016/s0092-1157(79)80024-4. [DOI] [PubMed] [Google Scholar]
